There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Wuxi Biologics (Cayman) (WXIBF) and Community Health (CYH) with bullish sentiments.TipRanks Welcomes a New ETF – NYSE:RANK TipRanks has entered a new arena in the investing world, powering the index of an ETF based on its unique data now trading under the ticker RANK on the NYSE. RANK tracks the performance of the TipRanks US Momentum Analysts Index, a rules-based index of 50 large U.S. companies.
Wuxi Biologics (Cayman) (WXIBF)
Morgan Stanley analyst Laurence Tam maintained a Buy rating on Wuxi Biologics (Cayman) on July 9 and set a price target of HK$50.00. The company’s shares closed last Wednesday at $4.60.
Tam has an average return of 6.7% when recommending Wuxi Biologics (Cayman).
According to TipRanks.com, Tam is ranked #8290 out of 12381 analysts.
